The overexpressions of ERCC1 and ACTL6A were found to significantly enhance the infiltration of CD8+ T-cells, macrophages, dendritic cells, CD4+ T-cells, and B-cells into HNC tumor cells (Figure 3D, Supplementary Figure S5). Here, ACTL6A is linked to neoplasm.